A U.S. appeals court has reinstated more than 500 lawsuits against drugmaker Merck & Co. because of its osteoporosis drug Fosamax, which plaintiffs allege increases risk of thigh bone fractures, ...
U.S. stocks closed higher on Monday and the Dow and S&P 500 posted record highs, although the gains were just marginal, as investors ...
A U.S. appeals court revived a lawsuit on Friday by healthcare and drug industry groups challenging the first-ever U.S. law ...
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
The decision, which the U.S. Court of Appeals for the Third Circuit said was a close call, hinged on whether an informal ...
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks ...
In this clip, from Forbes 30 Under 30 Summit, Ken Frazier explains the benefits of investing in your economy. Frazier is an ...
Sutro Biopharma specializes in ADCs for oncology and shows promise with STRO-002 for ovarian cancer and collaborations with ...
The company, founded in 2016, says its solutions outdo human radiologists and physicians in diagnosing conditions like ...
The global Animal Antibacterial and Antibiotics Market is projected to grow from approximately USD 4.9 billion in 2024 to ...
And the agency expanded the approval of bimekizumab (Bimzelx) to include psoriatic arthritis, non-radiographic axial spondyloarthritis, and ankylosing spondylitis, UCB Announced.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback